Related Experiment Video
Updated: Jul 4, 2026

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
Small molecule inhibitors of Lck: the search for specificity within a kinase family
Malcolm A Meyn1, Thomas E Smithgall
1University of Pittsburgh School of Medicine, Department of Molecular Genetics and Biochemistry, 200 Lothrop St., Pittsburgh, PA 15213-2536, USA.
Abstract:
The Src family of non-transmembrane protein kinases is comprised of eleven homologous members in mammals. Together, these kinases regulate a wide variety of cellular processes including cell survival, proliferation, differentiation, and motility. One member of this family, Lck, plays a pivotal role in T-cell signaling. Inhibition of Lck with small molecules has significant potential for therapeutic immunosuppression and treatment of diseases such as rheumatoid arthritis and asthma. Critical for successful clinical use of any Lck inhibitor is high specificity for Lck as inhibition of other members of the Src kinase family may result in unwanted side effects. In this review we provide an overview of the various synthetic compounds currently under investigation as Lck-specific inhibitors. In addition we provide an analysis of the properties of these compounds that account for the specificity required for the inhibition of one of eleven highly similar kinases.
Insights
This review covers Lck-specific inhibitors, focusing on small molecules for T-cell signaling. Understanding compound properties is key to developing targeted therapies with fewer side effects.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- The Src family of protein kinases regulates critical cellular functions.
- Lck, a member of the Src family, is central to T-cell signaling pathways.
- Targeting Lck offers therapeutic potential for autoimmune diseases like rheumatoid arthritis and asthma.
Purpose of the Study:
- To review synthetic compounds investigated as Lck-specific inhibitors.
- To analyze the properties conferring specificity for Lck inhibition.
- To highlight the importance of Lck specificity for therapeutic applications.
Main Methods:
- Literature review of synthetic compounds targeting Lck.
- Analysis of structure-activity relationships for Lck inhibitors.
- Comparative analysis of Lck inhibitors against other Src family kinases.
Main Results:
- Several synthetic compounds are under investigation as Lck inhibitors.
- Specific molecular properties contribute to the selectivity of these inhibitors.
- High specificity is crucial to avoid off-target effects from inhibiting related kinases.
Conclusions:
- Lck-specific inhibitors hold promise for targeted immunosuppressive therapies.
- Further research into compound specificity is essential for clinical development.
- Selective inhibition of Lck can mitigate risks associated with broader Src kinase inhibition.
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Enzymatic Cascade
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...

